Search Main Menu Main Content
  • Change contrast :
Retour à l'accueil du site de la HAS
logo HAS
icone
  • HAS profile
    • Mission
    • Organisational Structure
    • Ethics, transparency and management of conflicts of interest
  • International relations and projects
  • Publications
  1. root
  2. ILUVIEN (acétonide de fluocinolone)
  • icone plus
  • My account

    • Email alert Subscription
    • Newsletter Subscription
    • My search
    Refresh
    Please fill in your email address to retrieve your email alerts subscriptions.
    New subscription
    Please fill in your email address to retrieve your newsletter subscriptions.

    You do not have a saved search

    Mon Compte
  • No element in selection

    Favoris
  • Établissements de santé
  • Contact Abonnez-vous aux actualités
Listen Listen
Add to my selection
  • History
  • Technical informations
Share
Share on
Facebook share - facebook.com - new window
Tweeter share - Partager sur Twitter - twitter.com - new window
LinkedIn share - linkedin.com - new window
Print

ILUVIEN (acétonide de fluocinolone)

Medicine - Posted on Nov 17 2021
Active substance (DCI)
  • acétonide de fluocinolone
history (2)
  • 9/22/21

    ILUVIEN 190 µg (acetonide de fluocinolone) (prevention rechute uveite)

    Key points Favourable opinion for reimbursement in the prevention of relapse in recurrent non-infectious uveitis affecting t...
    CAV :
    54321
    icône flèche
  • 6/26/13

    ILUVIEN (acétonide de fluocinolone), corticoïde en implant intravitréen

    ILUVIEN (acétonide de fluocinolone), corticoïde en implant intravitréen Progrès thérapeutique mineur dans le traitement des ...
    CAV :
    54321
    icône flèche
Technical information
ATC code
  • S01BA15
Manufacturer
NOVEX PHARMA
Presentation

ILUVIEN 190 microgrammes, implant intravitréen avec applicateur (code CIS : 61412157)
Boîte de 1 - (Code CIP : 34009 222 858 1 8)

All our publications
    Diabetes mellitus Drug therapy Eye diseases Pain - Inflammation Protheses and implants

Follow us :

  • Twitter (nouvelle fenêtre)
  • Facebook (nouvelle fenêtre)
  • Youtube (nouvelle fenêtre)
  • LinkedIn (nouvelle fenêtre)
Haute Autorité de Santé
Advancing quality in the fields of health and social care services
  • Eunetha.eu
  • Pasq.eu
  • All our publications by topic and type
  • Opinions on medicines
  • Opinions on medical devices
  • INAHTA briefs
  • Français
  • English
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
EneRwvMWvs0N76gp